[Effect of treatment with Melitracen (trausabun) in depressive states].
D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000009:adverse effects / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008297:Male; D008593:Menopause; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D011437:Propylamines / Q000009:adverse effects / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013997:Time Factors
D000873:Anthracenes; D000928:Antidepressive Agents; D011437:Propylamines
Wyniki leczenia stanów depresyjnych melitracenem (trausabunem)